Qube Research & Technologies (QRT)’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
Qube Research & Technologies (QRT)'s PRTA Position: Q3 2026 in Review
Qube Research & Technologies (QRT) reduced its Prothena Corp (PRTA) stake by 41% in Q3 2026, selling an estimated $2.93M and leaving 462,862 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1956.
Qube Research & Technologies (QRT) first reported a position in PRTA in Q2 2020 and has held it in 18 quarters since. The position peaked at $7.75M in Q2 2026. 123 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.
- Qube Research & Technologies (QRT) held 462,862 shares of Prothena Corp worth $3.88M as of Q3 2026.
- Qube Research & Technologies (QRT) sold 328,307 Prothena Corp shares in Q3 2026, an estimated $2.93M.
- Prothena Corp made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1956 holding.
- Qube Research & Technologies (QRT) first reported a position in Prothena Corp in Q2 2020 and has held it in 18 quarters since.
- Qube Research & Technologies (QRT)'s Prothena Corp position peaked at $7.75M in Q2 2026.
- 123 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.